ASTH · Astrana Health, Inc.
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted net income attributable to Astrana Health, Inc. non-GAAP | 39.77M | the three months ended June 30, 2026 filing | — |
| EBITDA non-GAAP | 52.85M | the three months ended June 30, 2026 filing | — |
| Adjusted EBITDA non-GAAP | 135.2M | Six Months Ended June 30, 2026 | — |
| Adjusted EBITDA margin non-GAAP | 7% | Six Months Ended June 30, 2026 | — |
| Adjusted EPS - diluted non-GAAP | $1.54 | Six Months Ended June 30, 2026 | — |
| Free cash flow non-GAAP | 92.9M | Six Months Ended June 30, 2026 | — |
| members in our Care Partners segment | 1.2M | Q2 2026 | — |
| patients in value-based arrangements | 1.5M | Q2 2026 | — |
| Q2 2026 capitation revenue from full-risk arrangements | 81% | Q2 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ASTH
this stock
Astrana Health, Inc.
|
$1.95B | +44.6% | +45.9% | 42.7 | 5.9% |
|
HCA
HCA Healthcare, Inc.
|
$96.64B | -8.6% | +7.1% | 15.0 | 2.9% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$29.92B | -13.3% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$20.91B | +30.1% | +0.9% | 10.0 | 2.5% |
|
EHC
Encompass Health Corp
|
$12.18B | +12.9% | +10.5% | 20.1 | 3.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ASTH | -1.4% | -5.2% | +24.2% | +0.9% | +44.6% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | -1.1% | -4.7% | +12.1% | -0.1% | +31.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.